Report cover image

Pneumonia Therapeutics Global Market Report 2025

Published Sep 10, 2025
Length 250 Pages
SKU # BRC20385793

Description

Pneumonia Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pneumonia therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for pneumonia therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pneumonia therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Product: Drugs; Vaccine; Oxygen Therapy

2) By Infection: Hospital-Acquired Pneumonia (HAP); Community-Acquired Pneumonia (CAP); Ventilator-Associated Pneumonia (VAP)

3) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration

4) By End Use: Hospitals; Homecare; Specialty Clinics; Other End Users

Subsegments:

1) By Drugs: Antibiotics; Antiviral Drugs; Antifungal Drugs; Corticosteroids; Other Drugs

2) By Vaccine: Pneumococcal Vaccines; Haemophilus Influenzae Type B (Hib) Vaccines; Influenza Vaccines; Other Vaccines

3) By Oxygen Therapy: High-Flow Nasal Cannula (HFNC); Non-Invasive Ventilation (NIV); Mechanical Ventilation; Other Oxygen Therapies

Companies Mentioned: Pfizer Inc.; Roche AG; Merck & Co. Inc.; AbbVie Inc; Bayer AG; Sanofi S.A.; AstraZeneca PLC; Abbott Laboratories; Novartis AG; GSK plc; Eli Lilly and Company; Astellas Pharma Inc.; Eisai Co. Ltd.; Sun Pharmaceutical Industries Ltd.; Cipla Inc.; Hikma Pharmaceuticals PLC; Shionogi & Co. Ltd; Lupin Limited; Swedish Orphan Biovitrum AB; Nabriva Therapeutics plc; TaiGen Biotechnology Co. Ltd; Aridis Pharmaceuticals Inc.; Tergene Biotech Limited.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

250 Pages
1. Executive Summary
2. Paraganglioma Market Characteristics
3. Paraganglioma Market Trends And Strategies
4. Paraganglioma Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Paraganglioma Growth Analysis And Strategic Analysis Framework
5.1. Global Paraganglioma PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Paraganglioma Market Growth Rate Analysis
5.4. Global Paraganglioma Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Paraganglioma Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Paraganglioma Total Addressable Market (TAM)
6. Paraganglioma Market Segmentation
6.1. Global Paraganglioma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Sympathetic Paragangliomas
Parasympathetic Paragangliomas
Caroid Paragangliomas
Cervical Paragangliomas
Jugular Paragangliomas
Secretory Paragangliomas
Temporal Paragangliomas
6.2. Global Paraganglioma Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Head And Neck
Abdomen
Pelvis
Other Origins
6.3. Global Paraganglioma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Peptide Receptor Radionuclide Therapy
Surgery
Chemotherapy
Radiation Therapy
Other Treatment Types
6.4. Global Paraganglioma Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Drug Stores And Retail Pharmacies
Online Pharmacies
6.5. Global Paraganglioma Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialty Clinics
Cancer Research Institutes
Other End-Users
6.6. Global Paraganglioma Market, Sub-Segmentation Of Sympathetic Paragangliomas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Adrenal Sympathetic Paragangliomas
Extra-Adrenal Sympathetic Paragangliomas
6.7. Global Paraganglioma Market, Sub-Segmentation Of Parasympathetic Paragangliomas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Head And Neck Parasympathetic Paragangliomas
Thoracic Parasympathetic Paragangliomas
6.8. Global Paraganglioma Market, Sub-Segmentation Of Carotid Paragangliomas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Unilateral Carotid Paragangliomas
Bilateral Carotid Paragangliomas
6.9. Global Paraganglioma Market, Sub-Segmentation Of Cervical Paragangliomas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Vagal Paragangliomas
Hypoglossal Paragangliomas
6.10. Global Paraganglioma Market, Sub-Segmentation Of Jugular Paragangliomas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Type A
Type B
Type C
Type D
6.11. Global Paraganglioma Market, Sub-Segmentation Of Secretory Paragangliomas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Catecholamine-Secreting Paragangliomas
Non-Catecholamine-Secreting Paragangliomas
6.12. Global Paraganglioma Market, Sub-Segmentation Of Temporal Paragangliomas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tympanic Paragangliomas
Mastoid Paragangliomas
7. Paraganglioma Market Regional And Country Analysis
7.1. Global Paraganglioma Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Paraganglioma Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Paraganglioma Market
8.1. Asia-Pacific Paraganglioma Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Paraganglioma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Paraganglioma Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Paraganglioma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Paraganglioma Market
9.1. China Paraganglioma Market Overview
9.2. China Paraganglioma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Paraganglioma Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Paraganglioma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Paraganglioma Market
10.1. India Paraganglioma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Paraganglioma Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Paraganglioma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Paraganglioma Market
11.1. Japan Paraganglioma Market Overview
11.2. Japan Paraganglioma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Paraganglioma Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Paraganglioma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Paraganglioma Market
12.1. Australia Paraganglioma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Paraganglioma Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Paraganglioma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Paraganglioma Market
13.1. Indonesia Paraganglioma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Paraganglioma Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Paraganglioma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Paraganglioma Market
14.1. South Korea Paraganglioma Market Overview
14.2. South Korea Paraganglioma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Paraganglioma Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Paraganglioma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Paraganglioma Market
15.1. Western Europe Paraganglioma Market Overview
15.2. Western Europe Paraganglioma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Paraganglioma Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Paraganglioma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Paraganglioma Market
16.1. UK Paraganglioma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Paraganglioma Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Paraganglioma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Paraganglioma Market
17.1. Germany Paraganglioma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Paraganglioma Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Paraganglioma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Paraganglioma Market
18.1. France Paraganglioma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Paraganglioma Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Paraganglioma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Paraganglioma Market
19.1. Italy Paraganglioma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Paraganglioma Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Paraganglioma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Paraganglioma Market
20.1. Spain Paraganglioma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Paraganglioma Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Paraganglioma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Paraganglioma Market
21.1. Eastern Europe Paraganglioma Market Overview
21.2. Eastern Europe Paraganglioma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Paraganglioma Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Paraganglioma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Paraganglioma Market
22.1. Russia Paraganglioma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Paraganglioma Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Paraganglioma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Paraganglioma Market
23.1. North America Paraganglioma Market Overview
23.2. North America Paraganglioma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Paraganglioma Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Paraganglioma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Paraganglioma Market
24.1. USA Paraganglioma Market Overview
24.2. USA Paraganglioma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Paraganglioma Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Paraganglioma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Paraganglioma Market
25.1. Canada Paraganglioma Market Overview
25.2. Canada Paraganglioma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Paraganglioma Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Paraganglioma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Paraganglioma Market
26.1. South America Paraganglioma Market Overview
26.2. South America Paraganglioma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Paraganglioma Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Paraganglioma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Paraganglioma Market
27.1. Brazil Paraganglioma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Paraganglioma Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Paraganglioma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Paraganglioma Market
28.1. Middle East Paraganglioma Market Overview
28.2. Middle East Paraganglioma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Paraganglioma Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Paraganglioma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Paraganglioma Market
29.1. Africa Paraganglioma Market Overview
29.2. Africa Paraganglioma Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Paraganglioma Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Paraganglioma Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Paraganglioma Market Competitive Landscape And Company Profiles
30.1. Paraganglioma Market Competitive Landscape
30.2. Paraganglioma Market Company Profiles
30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Merck & Co. Inc.  Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Mount Sinai Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Penn Medicine Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Stanford Health Care Overview, Products and Services, Strategy and Financial Analysis
31. Paraganglioma Market Other Major And Innovative Companies
31.1. St. Jude Children's Research Hospital
31.2. UT Health San Antonio
31.3. The University of Chicago Medical Center
31.4. Fred Hutchinson Cancer Center
31.5. Florida Cancer Specialists & Research Institute
31.6. Invitae Corp.
31.7. Clinigen Group plc
31.8. Fulgent Genetics
31.9. Dana-Farber Cancer Institute Inc.
31.10. Oncology Hematology Care Inc.
31.11. Enterome 
31.12. National Institutes of Health Clinical Center
31.13. Progenics Pharmaceuticals Inc.
31.14. Pheo Para Alliance
31.15. Saint John’s Cancer Institute
32. Global Paraganglioma Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Paraganglioma Market
34. Recent Developments In The Paraganglioma Market
35. Paraganglioma Market High Potential Countries, Segments and Strategies
35.1 Paraganglioma Market In 2029 - Countries Offering Most New Opportunities
35.2 Paraganglioma Market In 2029 - Segments Offering Most New Opportunities
35.3 Paraganglioma Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.